Detalhe da pesquisa
1.
Liraglutide and cardiovascular outcomes in adults with overweight or obesity: A post hoc analysis from SCALE randomized controlled trials.
Diabetes Obes Metab
; 20(3): 734-739, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28950422
2.
LEADER 5: prevalence and cardiometabolic impact of obesity in cardiovascular high-risk patients with type 2 diabetes mellitus: baseline global data from the LEADER trial.
Cardiovasc Diabetol
; 15: 29, 2016 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-26864124
3.
LEADER 2: baseline calcitonin in 9340 people with type 2 diabetes enrolled in the Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Results (LEADER) trial: preliminary observations.
Diabetes Obes Metab
; 17(5): 477-86, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25656058
4.
Liraglutide for weight management: a critical review of the evidence.
Obes Sci Pract
; 3(1): 3-14, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28392927
5.
Neointimal hyperplasia after arterial injury is increased in a rat model of non-insulin-dependent diabetes mellitus.
Circulation
; 104(7): 815-9, 2001 Aug 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-11502708
6.
Enhanced efficacy of eptifibatide administration in patients with acute coronary syndrome requiring in-hospital coronary artery bypass grafting. PURSUIT Investigators.
Circulation
; 102(24): 2952-8, 2000 Dec 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-11113045
7.
The importance of proteinuria as a determinant of mortality following percutaneous coronary revascularization in diabetics.
J Am Coll Cardiol
; 33(5): 1269-77, 1999 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-10193727
8.
Abciximab reduces mortality in diabetics following percutaneous coronary intervention.
J Am Coll Cardiol
; 35(4): 922-8, 2000 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-10732889
9.
Procedural outcomes and long-term survival among patients undergoing percutaneous coronary intervention of a chronic total occlusion in native coronary arteries: a 20-year experience.
J Am Coll Cardiol
; 38(2): 409-14, 2001 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-11499731
10.
Effectiveness of percutaneous coronary interventions to prevent recurrent coronary events in patients on chronic hemodialysis.
Am J Cardiol
; 82(3): 378-80, 1998 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-9708670
11.
Chest pain--a strong predictor of adverse cardiac events following precutaneous intervention (from the Evaluation of Platelet IIb/IIIa Inhibitor for Stenting Trial [EPISENT])].
Am J Cardiol
; 84(11): 1350-3, A8, 1999 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-10614805
12.
Catheter-based reperfusion of unprotected left main stenosis during an acute myocardial infarction (the ULTIMA experience). Unprotected Left Main Trunk Intervention Multi-center Assessment.
Am J Cardiol
; 83(11): 1513-7, 1999 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-10363863
13.
Immediate coronary artery bypass surgery after platelet inhibition with eptifibatide: results from PURSUIT. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrelin Therapy.
Ann Thorac Surg
; 70(3): 866-71; discussion 871-2, 2000 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-11016325
14.
Intracoronary stenting: an overview for the clinician.
Cleve Clin J Med
; 66(7): 434-42, 1999.
Artigo
em Inglês
| MEDLINE | ID: mdl-10410442
15.
Increase in interleukin-6 following arterial injury is related to insulin resistance, the -174G-->C polymorphism and complex plaque morphology.
Int J Immunogenet
; 33(5): 347-54, 2006 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-16984279
16.
Diabetes mellitus: biological determinants of atherosclerosis and restenosis.
Semin Interv Cardiol
; 4(3): 129-43, 1999 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-10545619
17.
Optimizing percutaneous coronary revascularization in diabetic women: analysis from the EPISTENT trial.
J Womens Health Gend Based Med
; 9(7): 741-6, 2000 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-11025866
18.
Proteinuria is a key determinant of death in patients with diabetes after isolated coronary artery bypass grafting.
Am Heart J
; 139(6): 939-44, 2000 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-10827372
19.
Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus: results of the EPISTENT (Evaluation of platelet IIb/IIIa inhibitor for stenting trial) diabetic substudy.
Circulation
; 100(25): 2477-84, 1999.
Artigo
em Inglês
| MEDLINE | ID: mdl-10604884
20.
The paradoxical benefit of sulfonylurea agents in diabetics undergoing coronary revascularization.
Eur Heart J
; 19(11): 1601-3, 1998 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-9857909